According to the company’s press statement, the portfolio includes the Biorphen® (phenylephrine hydrocholoride) Injection and Rezipres® (ephedrine hydrochloride) Injection NDAs…
According to the company’s press statement, the portfolio includes the Biorphen® (phenylephrine hydrocholoride) Injection and Rezipres® (ephedrine hydrochloride) Injection NDAs…
Moreover, both the companies – Ahammune Biosciences and Veeda Clinical Research – anticipate that this new drug has a great…
Recently, the Drugs Controller General of India (DCGI) approved Corbevax as a precaution dose for those aged 18 and above.
The company revealed that in the phase 3 clinical trial, approximately 30 percent of patients developed edema or fluid retention…
Reportedly, this was based on findings from seven double-blind, randomised, clinical trials that evaluated the safety, tolerability and immunogenicity of…
On Thursday, the first emergency committee meeting on the ongoing Monkeypox outbreak took place and the members are likely to…
Japan’s Maruho Co. Ltd is also working on a prurigo nodularis treatment while French drugmaker Sanofi is running trials to…
In 2008, Europe’s first approved biosimilar came in, and after 15 more received approval. However, in the eight years after…
According to WHO annual analyses, in 2021 there were only 27 new antibiotics in clinical development against priority pathogens, down…
According to the company’s press statement, Tafinlar + Mekinist is the first and only BRAF/MEK inhibitor to be approved with…
Globally, 1.7 billion people suffer from NTDs, which are prevalent in tropical areas and mostly affect impoverished communities, causing devastating…
With the launch of this feature, Sirona will provide a key utility to all menstruators literally at their fingertips, the…
The data and analytics company also noted that the National Technical Advisory Group on Immunisation recommended including HPV vaccination under…
According to the hospital, the association between Le Crest and AVISA Smart Hospitals is expected to increase the footfall of…
Novartis has settled patent cases with several other generic drugmakers, paving the way for some Gilenya generics to be introduced…
Moreover, there are no necessary calculations or insulin dose inputs. Beta Bionics has not yet received approval from the FDA…
Under the revised deal, Valneva will now fund 40 percent of the remaining shared development costs compared to 30% before.…
The fertility chain is planning to provide quality In Vitro Fertilization (IVF) services at affordable prices to every household in…